Skip to main content

Eckert&Ziegler Value Stock - Dividend - Research Selection

Eckert & Ziegler Strahlen- und Medizintechnik AG

ISIN: DE0005659700, WKN: 565970

Market price date: 13.07.2021
Market price: 101,20 EUR




Eckert & Ziegler Strahlen- und Medizintechnik AG Fundamental data and company key figures of the share

Annual reports in EUR
Key figures 27-04-2021
Cash flow
Net operating cash flow 36.786.000
Capital Expenditures -8.905.000
Free cash flow 27.881.000
Balance sheet
Total Equity 147.823.000
Liabilities & Shareholders equity 292.003.000
Income statement
Net income 22.884.000
Eps (diluted) 1,111
Diluted shares outstanding 20.590.000
Net sales/revenue 176.139.000

Fundamental ratios calculated on: 13-07-2021

Ratios
Key figures 13-07-2021
Cash flow
P/C 56,64
   
P/FC 74,74
Balance sheet
ROI7,84
ROE50,62
Income statement
P/E91,06
Div. Yield0,00%
P/B14,10
P/S11,83


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolEUZ.XETRA
Market Capitalization2.527.238.400,00 USD
Country
IndicesCDAX,HDAX,Prime All Share,SDAX,TecDAX
Sectors
Raw Data SourceIFRS in Millionen EUR
Stock Split2020-07-31,4.000000/1.000000; 2009-11-19,903.000000/845.000000; 2009-01-20,1522.000000/1435.000000; 2000-06-13,1613.000000/1581.000000
Internetwww.ezag.de


Description of the company

Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, provides isotope technology components for medical, scientific, and industrial use worldwide. It operates through three segments: Radiation Therapy, Radiopharma, and Isotope Products. The Radiation Therapy segment develops, manufactures, markets, and sells radioactive products for cancer therapy. This segment offers small radioactive implants for the treatment of prostate cancer seeds; and tumor radiation devices and eye applicators. This segment\'s products and equipment are used by oncologists, radiotherapists, urologists, ophthalmologists, and medical physicists. The Radiopharma segment operates in the field of molecular imaging and nuclear medicine; and supplies various radiopharmaceuticals, radiochemicals, and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. This segment provides products in the categories of radiosynthesis technology, radiochromatography, and radionuclides. The Isotope Products segment offers sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration, and environmental monitoring sources and solutions; and bulk radioisotopes for pharmaceutical, therapeutic, and industrial product manufacturers. It also provides custom and one-off design and manufacturing services. In addition, the company offers services for collection, recycling, and disposal of sealed radioactive sources and low activity isotope related waste from hospitals, research institutes, and industries. Eckert & Ziegler Strahlen- und Medizintechnik AG was founded in 1992 and is headquartered in Berlin, Germany.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.ezag.de